Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Icatibant manufacturers

7 products found

Filters

7 products found

icatibant

Injection, pre-filled syringe 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Firazyr®
Manufacturer #252

Manufacturer usually replies in 2 days

icatibant

Injection, pre-filled syringe 30 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 10 days

icatibant

Injection, pre-filled syringe 30 mg/3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Not available: EU, USA, Australia, Canada, MENA, GCC
Manufacturer #6301
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, MENA, LATAM, and NA for 20+ years. Main therapeutic area include oncology and urology. The company's production lines are GMP-compliant. The main dosage forms includes injectable. The company possesses subsidiaries in LATAM

Manufacturer usually replies in 3 days

icatibant

Injection, pre-filled syringe 30 mg/3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

icatibant

Injection, pre-filled syringe 30 mg/3 ml - 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, ANVISA
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

icatibant

Injection, pre-filled syringe 30 mg/3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Peru
Available for
Licensing with supply, Distribution only
Manufacturer #16394

Manufacturer usually replies in 12 days

icatibant

Injection, pre-filled syringe 30 mg/3 ml - 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #1430

Manufacturer usually replies in nan days

Icatibant

Icatibant is used in adults with C1-esterase-inhibitor deficiency for the symptomatic treatment of acute attacks of hereditary angioedema. However, Angioedema caused by medication from the ACE inhibitor class is not treated by Icatibant. It has been investigated for treating angioedema, liver disease, and burns and burn infections. Icatibant is classified as a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. Icatibant sold under the brand name Firazy among others. Shire plc was given the first FDA approval for its Firazyr in 2011. However, as of 2011, Icatibant has orphan drug status in the United States as per FDA approvals.

Dosage Forms & Strengths

Icatibant is sold as SC injection in a prefilled syringe in 30mg (10 mg/mL). in the treatment of Hereditary Angioedema, the Bradykinin B2 receptor antagonist indicated for the treatment of acute attacks is 3 mL (30 mg) SC in the abdominal area. If the desired response is not achieved from this dose, an injection of 30 mg can be administered at intervals of at least 6 hr, not to exceed 3 injections in 24 hours.

The price of Icatibant

In the USA, the price of generic subcutaneous solution (10 mg/mL) is around $2,950 for a supply of 3 milliliters and the price of Firazyr subcutaneous solution (10 mg/mL) is around $11,647 for a supply of 3 milliliters. The price is much lower in the developing world. In India, the price of one viral is around USD2.5.

How does it work?

Icatibant is a peptide-based hormone, it forms naturally in local tissues in response to trauma. This results in increased vessel permeability blood vessel dilation, and contraction in smooth muscle cells. It is a key mediator of pain and its excess is associated with typical symptoms of inflammation like swelling, redness, overheating, and pain. The resolution of these symptoms is done by activating bradykinin B2 receptors. Icatibant is a bradykinin inhibitor. Its actions block the binding of native bradykinin to the bradykinin B2 receptor, mediating the levels to normal, controlling symptoms of inflammation.

Finding Icatibant Manufacturers and Suppliers

The best way to find and gain access to Icatibant manufacturers and Icatibant suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Icatibant can be a time- consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Icatibant to work with. You can fine-tune your search results using various filters too, letting you search for Icatibant from specific countries.